U.S. government health plans spent over $1 billion on EpiPens over five years

(Reuters) - U.S. government health plans spent more than $1 billion on Mylan NV's EpiPen emergency allergic reaction treatment between 2011 and 2015, according to figures released by the Centers for Medicare and Medicaid Services on Wednesday.

U.S. government health plans spent over $1 billion on EpiPens over five years
Read More


Bagikan Berita Ini